November 2023 - Wellthy Therapeutics

Monthly Archives: November 2023

Advancing IBS Care in the Digital Era: Global Challenges, Innovative Solutions, and Future Perspectives

Introduction: Irritable bowel syndrome (IBS) is a globally prevalent gastrointestinal disorder, affecting a significant portion of the world’s population. This chronic condition is characterized by a constellation of symptoms, including abdominal discomfort, bloating, and irregular bowel movements, which can range from diarrhea to constipation. The global burden of IBS is substantial, with countless individuals experiencing

Gamification in DTx: Revolutionizing Patient Engagement and Payer ROI

​​In the ever-evolving landscape of healthcare and technology, a promising approach has emerged to bridge the gap between traditional medical interventions and engaging patient experiences: Digital Therapeutics Gamification, often referred to as DTx gamification. This innovative concept not only offers new avenues for improving patient outcomes but also presents opportunities for healthcare payers to optimize

DTx in Clinical Trials: The Ultimate Guide

  Digital therapeutics (DTx) are revolutionizing the landscape of clinical trials, offering innovative approaches to recruitment, patient engagement, data collection, and much more. This comprehensive guide explores how DTx is transforming each phase of clinical trials, ensuring more efficient, accurate, and participant-friendly processes. Recruitment and Enrollment Targeted Outreach: Leveraging digital platforms for participant identification. Pre-screening

Payers Transitioning to Value-Based Contracting: The Essential Role of Digital Therapeutics in Pharma Differentiation

  The life sciences industry is undergoing a major transition, driven by calls for more equitable access to medications and the need for drugs that deliver long-term value. Patients, payers, and legislators alike are pushing for change, signaling the end of the fixed cost-per-unit model and ushering in the era of value-based contracts (VBCs). With

Leveraging Digital Health in the Journey of Multiple Sclerosis: Diagnosis, Treatment, and Beyond

This position paper explores the pivotal role of digital health technologies in revolutionizing the management of Multiple Sclerosis (MS). The paper sheds light on the complex challenges MS patients endure and the sophisticated diagnostic processes they face. It then delves into the transformative potential of Software as a Medical Device (SaMD) and other digital tools in providing personalized care, enhancing patient monitoring, and fostering a comprehensive treatment paradigm. The conclusive remarks emphasize the collaborative dynamic among healthcare professionals, patients, and technology developers, advocating for a future where digital health interventions substantially improve the quality of life for those living with MS.